Richard D. Truesdell, Jr.
Lawyers
Filters
Editas Medicine $125 million follow-on offering
The stock is listed on the Nasdaq Global Select Market
Ventas Realty $862.5 million exchangeable senior notes offering
We advised Ventas on the transaction
TransMedics Group $460 million convertible senior notes offering
The convertible senior notes are due 2028
Privia Health Group $936 million secondary offering
We advised Privia on the registered secondary offering
Nikola $100 million follow-on offerings
The shares are listed on Nasdaq
Marsh McLennan $600 million senior notes offering
We advised Marsh McLennan on its investment-grade notes offering
Hamilton Lane $51.7 million follow-on offering
The shares are listed on the Nasdaq Stock Market
Cigna $1.5 billion senior notes offering
The senior notes are due 2026 and 2033
Assurant $175 million senior notes offering
We advised Assurant on the senior notes offering
CureVac $250 million follow-on offering
We advised CureVac on the equity offering